This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 May;181(5):1994-7.

doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14.

The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer

Ralph W deVere White¹, Mark H Katz, Gary D Steinberg

Affiliations

PMID: 19286209
DOI: 10.1016/j.juro.2009.02.052

Review

The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer

Ralph W deVere White et al. J Urol. 2009 May.

. 2009 May;181(5):1994-7.

doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14.

Authors

Ralph W deVere White¹, Mark H Katz, Gary D Steinberg

Affiliation

¹ Department of Urology, University of California, Davis School of Medicine, Sacramento, California, USA.

PMID: 19286209
DOI: 10.1016/j.juro.2009.02.052

No abstract available

PubMed Disclaimer

Similar articles

Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T; Cancer Registration Committee of the Japanese Urological Association. Kikuchi E, et al. Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20. Int J Urol. 2009. PMID: 19207609
The optimal management of T1G3 bladder cancer.
Emiliozzi P, Pansadoro A, Pansadoro V. Emiliozzi P, et al. BJU Int. 2008 Nov;102(9 Pt B):1265-73. doi: 10.1111/j.1464-410X.2008.07969.x. BJU Int. 2008. PMID: 19035891 Review. No abstract available.
An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S. Tsukamoto S, et al. Scand J Urol Nephrol. 2002;36(5):339-43. doi: 10.1080/003655902320783836. Scand J Urol Nephrol. 2002. PMID: 12487737
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Milowsky MI, Stadler WM, Bajorin DF. Milowsky MI, et al. BJU Int. 2008 Nov;102(9 Pt B):1339-44. doi: 10.1111/j.1464-410X.2008.07980.x. BJU Int. 2008. PMID: 19035902 Review.
The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.
Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H. Splinter TA, et al. Prog Clin Biol Res. 1990;353:219-24. Prog Clin Biol Res. 1990. PMID: 2217422 Clinical Trial. No abstract available.

See all similar articles

Cited by

Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
Tollefson MK, Boorjian SA, Farmer SA, Frank I. Tollefson MK, et al. World J Urol. 2012 Dec;30(6):795-9. doi: 10.1007/s00345-012-0855-8. Epub 2012 Mar 25. World J Urol. 2012. PMID: 22447397
Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?
Chandrasekar T, Pugashetti N, Durbin-Johnson B, Dall'Era MA, Evans CP, deVere White RW, Yap SA. Chandrasekar T, et al. Bladder Cancer. 2016 Oct 27;2(4):441-448. doi: 10.3233/BLC-160071. Bladder Cancer. 2016. PMID: 28035325 Free PMC article.
Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.
May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM. May M, et al. World J Urol. 2015 Mar;33(3):343-50. doi: 10.1007/s00345-014-1308-3. Epub 2014 May 10. World J Urol. 2015. PMID: 24817140
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial.
Zibelman M, Asghar AM, Parker DC, O'Neill J, Wei S, Greenberg RE, Smaldone MC, Chen DYT, Viterbo R, Uzzo RG, Bloom E, Kokate R, Geynisman DM, Ghatalia P, Deng M, Ross EA, Plimack E, Abbosh PH, Kutikov A. Zibelman M, et al. J Urol. 2021 Jun;205(6):1605-1611. doi: 10.1097/JU.0000000000001602. Epub 2021 Feb 4. J Urol. 2021. PMID: 33535799 Free PMC article.
Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States.
Keegan KA, Zaid HB, Patel SG, Chang SS. Keegan KA, et al. Curr Urol Rep. 2014 Apr;15(4):394. doi: 10.1007/s11934-014-0394-5. Curr Urol Rep. 2014. PMID: 24566815 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information